Nicholas Investment Partners’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-19,388
| Closed | -$2.8M | – | 200 |
|
|
2020
Q1 | $2.8M | Sell |
19,388
-17,723
| -48% | -$2.56M | 0.54% | 77 |
|
|
2019
Q4 | $7.59M | Sell |
37,111
-17,880
| -33% | -$3.66M | 0.78% | 21 |
|
|
2019
Q3 | $4.42M | Buy |
54,991
+13,382
| +32% | +$1.07M | 0.37% | 104 |
|
|
2019
Q2 | $3.93M | Buy |
41,609
+16,278
| +64% | +$1.54M | 0.36% | 101 |
|
|
2019
Q1 | $2.17M | Buy |
+25,331
| New | +$2.17M | 0.19% | 163 |
|